Nplate and Amoxicillin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nplate (romiplostim) and Amoxicillin (amoxicillin). Common drug interactions include intervertebral disc degeneration among females and thrombocytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Nplate and Amoxicillin. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Nplate?

Nplate has active ingredients of romiplostim. It is often used in idiopathic thrombocytopenic purpura (itp). eHealthMe is studying from 17,850 Nplate users. Check the latest studies of Nplate.

What is Amoxicillin?

Amoxicillin has active ingredients of amoxicillin. It is often used in infection. eHealthMe is studying from 99,235 Amoxicillin users. Check the latest studies of Amoxicillin.



On Jul, 13, 2026

47 people who take Nplate and Amoxicillin together, and have interactions are studied.

Nplate and Amoxicillin drug interactions.

What are the common drug interactions of Nplate and Amoxicillin, by gender? *:

female:

  1. Intervertebral disc degeneration (spinal disc degeneration)
  2. Intervertebral disc protrusion (spinal disc protrusion)
  3. Lethargy (tiredness)
  4. Localised oedema (fluid retention in a particular part of the body)
  5. Metastases to bone (cancer spreads to bone)
  6. Metastases to pelvis (cancer spreads to pelvis)
  7. Metastases to spine (cancer spreads to spine)
  8. Myalgia (muscle pain)
  9. Neuropathy peripheral (surface nerve damage)
  10. Onychomycosis (fungal infection of the nail)

male:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Lymphoma (cancer that begins in immune system cells)
  3. Enterocolitis infectious
  4. Fatigue (feeling of tiredness)
  5. Hypokalaemia (low potassium)
  6. Influenza like illness
  7. Leukocytosis (increased white blood cells)
  8. Petechiae (a small red or purple spot caused by bleeding into the skin)
  9. Pseudohyperkalaemia (marked increase of in vitro serum potassium levels)
  10. Purpura (purplish discoloration of the skin)

What are the common drug interactions of Nplate and Amoxicillin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Pneumonia
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Wound secretion
  4. Drug ineffective
  5. Lymphoma (cancer that begins in immune system cells)
  6. Splenomegaly (enlargement of spleen)
  7. Therapeutic response decreased (less preventive response)
  8. Arthralgia (joint pain)
  9. Back pain
  10. Blood triglycerides increased

20-29:

  1. Pain in extremity

30-39:

n/a

40-49:

  1. Blood glucose decreased
  2. Erythema (redness of the skin)
  3. Fatigue (feeling of tiredness)
  4. Feeling hot
  5. Flushing (the warm, red condition of human skin)
  6. Headache (pain in head)
  7. Injection site pain
  8. Lethargy (tiredness)
  9. Myalgia (muscle pain)
  10. Pain

50-59:

  1. Marrow hyperplasia (increased bone marrow)
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Abdominal pain
  4. Acute respiratory failure
  5. Asthenia (weakness)
  6. Bone marrow reticulin fibrosis (thickening and scarring of bone marrow reticulin)
  7. Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
  8. Coagulopathy (blood's ability to clot is impaired)
  9. Drug hypersensitivity
  10. Insomnia (sleeplessness)

60+:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Anaemia (lack of blood)
  3. Petechiae (a small red or purple spot caused by bleeding into the skin)
  4. Pseudohyperkalaemia (marked increase of in vitro serum potassium levels)
  5. Purpura (purplish discoloration of the skin)
  6. Septic shock (shock due to blood infection)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Urinary hesitation (difficulty in beginning the flow of urine)
  9. Urinary tract obstruction
  10. Volvulus (obstruction caused by twisting of the stomach or intestine)

What are the existing conditions these people have? *

  1. Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 29 people, 61.70%
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 10 people, 21.28%
  3. Anaemia (lack of blood): 6 people, 12.77%

* Approximation only. Some reports may have incomplete information.

Do you take Nplate and Amoxicillin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nplate and Amoxicillin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nplate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Amoxicillin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nplate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amoxicillin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on romiplostim and amoxicillin (the active ingredients of Nplate and Amoxicillin, respectively), and Nplate and Amoxicillin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: